Search
Close this search box.
    • Small Molecules
      • Discovery
    • Biologics
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery
      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

    • Industries
    • Emerging Biopharma
      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

    • Dedicated Centers
      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

    • Center for Advanced Protein Studies (CAPS)
      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

  • Careers
Search
Close this search box.

Tax on Dividend Information 2024

Communication to shareholders on Final Dividend

Annexure 1 – Declaration from resident shareholders

Annexure 2- Form No 15G

Annexure 3 – Form No 15H

Annexure 4 – Declaration from non-resident shareholders

Annexure 5 -Form 10F

Annexure 6 – Declaration from Non Resident not having PAN

Annexure 7 – Declaration for deduction of TDS in the name of other person

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details